Baird Financial Group
ACAD icon

Baird Financial Group’s Acadia Pharmaceuticals ACAD Stock Holding History

Baird Financial Group’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-90,864
Closed -$1.51M – 1766
2025
Q1 		$1.51M Buy
+90,864
New +$1.51M ﹤0.01% 1052